H2R546 (H2R546_PANTR) Pan troglodytes (Chimpanzee)

Phosphodiesterase UniProtKBInterProSTRINGInteractive Modelling

941 aa; Sequence (Fasta) ; 3 identical sequences: Homo sapiens: O00408; Pan troglodytes: A0A6D2W1U4; Pan paniscus: A0A2R9BH84

Available Structures

42 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of of PDE2-inhibitor complex
4jib
homo-4-mer579-916
4×ZN; 4×MG; 4×1L6;
Assess
X-ray structure of PDE2A
3ibj
homo-2-mer223-900
2×ZN; 2×MG;
Assess
Crystal structure of human phosphodiesterase 2A in complex with 6-methyl-N-(1-(4-(trifluoromethoxy)…
5xkm
homo-2-mer579-918
3×MG; 2×ZN; 2×87R;
Assess
[1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2 Inhibitors
6zqz
homo-2-mer579-917
2×ZN; 2×MG; 2×QOQ;
Assess
Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-m…
5vp1
homo-2-mer579-916
2×ZN; 3×MG; 2×9GA;
Assess
Crystal structure of PDE2 catalytic domain in complex with BAY60-7550
4htx
homo-2-mer579-916
2×ZN; 2×MG; 2×19F;
Assess
Crystal structure of PDE2 catalytic domain in space group P1
4htz
homo-2-mer579-916
2×ZN; 2×MG;
Assess
PDE2 in complex with compound 5
6cyc
homo-2-mer581-916
2×ZN; 2×MG; 2×FKJ; 11×EDO;
Assess
PDE2 in complex with compound 7
6cyb
homo-2-mer581-916
2×ZN; 2×MG; 8×EDO; 2×FKV;
Assess
PDE2 in complex with compound 7
6cyd
homo-2-mer581-916
2×ZN; 2×MG; 2×FKG; 3×EDO;
Assess
Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-m…
5vp0
homo-2-mer583-916
2×ZN; 2×MG; 2×9GJ;
Assess
PDE2 in complex with molecule 5
6ezf
monomer580-919
1×MG; 1×ZN; 1×C6Z; 2×GOL; 1×SO4; 1×NA;
Assess
The Crystal Structure of the Phosphodiesterase 2A Catalytic Domain
1z1l
monomer576-915
1×ZN; 1×MG; 1×PO4;
Assess
Crystal Structure of human PDE2a in complex with (5S)-1-[(3-bromo-4-fluorophenyl)carbonyl]-3,3-difl…
5tzc
monomer579-918
1×7OJ; 1×ZN; 1×MG;
Assess
PDE2a catalytic domain in complex with a brain penetrant inhibitor
4d09
monomer579-918
1×788; 1×ZN; 1×MG;
Assess
Crystal structure of human phosphodiesterase 2A with 1-(2-chlorophenyl)-N,4-dimethyl-[1,2,4]triazol…
6c7e
monomer579-917
1×EOG; 1×ZN; 1×MG;
Assess
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3,4-difluorophenyl)carbonyl]-3,…
5tzw
monomer579-917
1×7P4; 1×ZN; 1×MG;
Assess
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3-bromo-4-fluorophenyl)carbonyl…
5tzz
monomer579-917
1×7OJ; 1×ZN; 1×MG;
Assess
Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-methoxy-phenyl)-N-isobutyl-4-met…
6c7i
monomer579-917
1×EP7; 1×ZN; 1×MG;
Assess
Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chlorophenyl)-4-methyl-[1…
6c7d
monomer579-917
1×EOJ; 1×ZN; 1×MG;
Assess
Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-isobutoxy-phenyl)-N,4-dimethyl-[…
6c7f
monomer579-917
1×EOS; 1×ZN; 1×MG;
Assess
Crystal structure of human phosphodiesterase 2A with 1-(5-tert-butoxy-2-chloro-phenyl)-N-isobutyl-4…
6c7j
monomer579-917
1×EPV; 1×ZN; 1×MG;
Assess
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3-chloro-4-fluorophenyl)carbony…
5tzx
monomer579-917
1×7OY; 1×ZN; 1×MG;
Assess
PDE2a catalytic domain in complex with a brain penetrant inhibitor
4d08
monomer579-917
1×ZN; 1×Q2T; 1×MG;
Assess
PDE2 catalytic domain complexed with inhibitors
5u7l
monomer579-917
1×7Y4; 1×ZN; 1×MG;
Assess
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 3,3-difluoro-1-[(4-fluoro-3-iodophe…
5u00
monomer579-916
1×7OV; 1×ZN; 1×MG;
Assess
hPDE2A catalytic domain complexed with IBMX
3itu
monomer579-916
1×ZN; 1×MG; 1×IBM;
Assess
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 3,3-difluoro-1-[(4-fluorophenyl)car…
5tzh
monomer579-916
1×7OP; 1×ZN; 1×MG;
Assess
Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chloro-5-isobutoxy-phenyl…
6c7g
monomer579-916
1×EOY; 1×ZN; 1×MG;
Assess
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A WITH 3-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-…
5tza
monomer579-916
1×7OG; 1×ZN; 1×MG;
Assess
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX with [1,2,4]triazolo[1,5-a]pyrimidin-7-y…
5tz3
monomer579-916
1×7OM; 1×ZN; 1×MG;
Assess
PDE2 catalytic domain complexed with inhibitors
5u7d
monomer579-916
1×19F; 1×ZN; 1×MG;
Assess
PDE2 catalytic domain complexed with inhibitors
5u7j
monomer579-916
1×7XV; 1×ZN; 1×MG;
Assess
PDE2 catalytic domain complexed with inhibitors
5u7i
monomer579-916
1×7XS; 1×ZN; 1×MG;
Assess
PDE2 catalytic domain complexed with inhibitors
5u7k
monomer579-916
1×ZN; 1×MG; 1×7Y1;
Assess
PDE2 complexed with 2-[6-fluoro-8-methylsulfonyl-9-[(1R)-1-[4-(trifluoromethyl)phenyl]ethyl]-1,2,3,…
6blf
monomer579-916
1×DY1; 1×ZN; 1×MG;
Assess
Crystal structure of PDE2 in complex with complex 9
6b97
monomer582-916
1×ZN; 1×MG; 1×CZY; 2×EDO;
Assess
Crystal Structure of PDE2 in complex with compound 16
6b96
monomer582-916
1×ZN; 1×MG; 1×CZV; 1×EDO;
Assess
PDE2 in complex with compound 1
6b98
monomer582-916
1×ZN; 1×MG; 1×D07;
Assess
[1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2 Inhibitors
6znd
monomer591-916
1×ZN; 1×MG; 1×QMZ;
Assess
Selective Inhibitors of PDE2, PDE9, and PDE10: Modulators of Activity of the Central Nervous System
4c1i
monomer581-905
1×EH9; 1×ZN; 1×MG;
Assess
Catalytic domain of hPDE2A
3itm
monomer588-901
1×ZN;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3ibj.1.Ahomo-2-mer0.80223-900
2×ZN; 1×MG;100.00
Assess
1mc0.1.Amonomer0.76223-562
1×PCG;94.99
Assess
3ibj.1.Ahomo-2-mer0.5649-398
19.18
Assess